The contracts are part of the NIH’s Rapid Acceleration of Diagnostics, or RADx, program it started in late April to speed the development of COVID-19 tests.
The money will support developing technologies for COVID-19 tests, such as portable point-of-care tests that can give immediate results. The new technologies will significantly increase the number, type and availability of tests by millions per week this fall, the NIH said.
The nine companies receiving the money are:
- MatMaCorp in Lincoln, Neb.
- Maxim Biomedical in Rockville, Md.
- MicroGEM International in Charlottesville, Va.
- Aegis Sciences in Nashville, Tenn.
- Broad Institute in Cambridge, Mass.
- Ceres Nanoscience in Manassas, Va.
- Illumina in San Diego
- PathGroup in Nashville, Tenn.
- Sonic Healthcare USA in Austin, Texas
Read the NIH’s full news release here.
More articles on supply chain:
Amazon’s delivery drones cleared for takeoff
US awards Abbott $760M contract for rapid COVID-19 tests
Medical device recalls rise 31% in Q2
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
